When Shane Hostetter arrived at Chemours in 2024, he stepped into a company facing liquidity challenges while also pursuing important long-term growth opportunities. His goal was not to replace decades of institutional knowledge but to complement it. Chemours CEO Denise Dignam brought nearly forty years of experience with DuPont and Chemours, while Hostetter brought an external perspective. Combining those viewpoints, he tells us, helped create “the best of both worlds.”
That approach reflects much of Hostetter’s broader leadership philosophy. Rather than viewing finance solely through the lens of reporting, he focuses on building a stronger foundation for future growth through disciplined capital allocation and balance sheet management.
Read More
Hostetter tells us the company developed a three-year strategy designed to strengthen Chemours over both the near and long term. Portfolio optimization became one important pillar, including shutting down selected production lines and divesting non-core assets to improve cash flow. Underlying every decision, he tells us, was a disciplined capital allocation strategy intended to improve financial flexibility.
At the same time, Hostetter has become an advocate for helping others better understand what Chemours actually does. Although many people still associate the company with its legacy DuPont products, he explains that Chemours today serves critical industrial markets ranging from next-generation refrigerants to semiconductor manufacturing, AI infrastructure, electric vehicles, and advanced cooling technologies.
Looking ahead, Hostetter’s emphasis remains consistent: strengthen the balance sheet, allocate capital thoughtfully, and position the company to create sustainable long-term value. For him, finance is ultimately about creating the platform that allows strategy to succeed.
CFOTL: When you’re out talking to people about Chemours today, what surprises them most about the company?
Hostetter: It’s interesting because Chemours was spun off from DuPont ten years ago, and many people still associate us primarily with those legacy products rather than the company we’ve become today. That’s something I spend a lot of time helping people understand.
The reality is that we have three businesses, each built around critical chemistry that supports many of the world’s essential needs. Most people recognize the Freon® brand, but today we’re developing next-generation refrigerants used in home air conditioning, automobiles, and commercial refrigeration. People also know the Teflon™ brand, but our business isn’t consumer products—it’s industrial applications. Our materials help protect equipment operating in high-heat or highly corrosive environments, making them essential for data centers, AI infrastructure, wiring, and cabling.
Read More
Our third business produces the titanium technologies that make paint, plastics, and paper white. In many ways, our products are part of everyday life, even though most people never realize it.
What’s especially exciting is that Chemours is participating in virtually every major industrial trend people are talking about today. Whether it’s advanced cooling technologies, AI data centers, semiconductors, electric vehicles, or critical minerals, our chemistry plays an important role. We have unique technologies supporting semiconductor manufacturing, wire and cable applications, and other emerging markets. I don’t think many people fully appreciate just how closely Chemours is connected to these growth opportunities—or the value that creates for our business.
CFOTL: You joined Chemours in mid-2024. What chapter are you helping write for the company?
Hostetter: When I joined in 2024, I brought an external perspective to a company with deep institutional knowledge. Denise, our CEO, has spent nearly forty years with DuPont and Chemours, so she knows the business better than almost anyone. My role has been to combine that internal expertise with fresh outside perspectives to create the best of both worlds.
Our focus has been executing a clear strategy built around strengthening the company over both the next three years and the long term. That includes optimizing our portfolio, whether through shutting down underperforming production lines or divesting non-core assets to improve cash flow. Underpinning all of it is a disciplined capital allocation strategy.
When I arrived, we were facing liquidity challenges and important strategic decisions about where to invest for future growth. We’ve worked hard to strengthen the balance sheet while creating a platform that positions Chemours to thrive over the long term.
Chemours | www.chemours.com | Wilmington, DE


